Posts by Btrep2025
Canadian Food Safety Research and Nutrition: Healthier Kitchens and Evidence
Canadian food safety research and nutrition connect everyday kitchen decisions with public-health evidence. For World Chefs Day on O...
Childhood Bone and Joint Health in Canada: Growth, Nutrition and Injury Prevention
Childhood bone and joint health in Canada brings together evidence on growth, physical activity, fractures, sports injury and pediat...
Retatrutide Canada: Research Guide to Mechanism, Clinical Trials and Regulatory Status
Retatrutide (development code LY3437943) is an investigational once-weekly medicine developed by Eli Lilly that activates three meta...
Bone Health Nutrition for Athletes: What World Osteoporosis Day Means for Lifters
Contents
Your Skeleton Is Training Too: The Remodeling Basics
Calcium: Hitting Your Number the Canadian Way
Vitamin D...
Petrelintide Trial Results: What Canadians Can Read From ZUPREME-2
petrelintide showed 7.4–9.2% mean weight loss in a US diabetes trial. See what the reported numbers mean, Canadian status and evidence gaps.
BPC-157 Recovery Claims: What Human Evidence Actually Exists?
The human evidence for bpc 157 canada recovery claims remains very limited. Published human reports include small studies involving ...
Peptides in Canada: Understanding Health Canada Authorization, Clinical Research and Regulatory Status
Understanding peptides in canada requires separating scientific research from Health Canada authorization. Some peptide-based medici...
Retatrutide Phase 3 Results: What the TRIUMPH-2 Trial Means for Canada
Explore the latest retatrutide Phase 3 results from TRIUMPH-2, weight-loss and A1C findings, Canadian clinical trials, and whether retatrutide is approved in Canada.
Retatrutide Phase 3 Results: What Canadians Should Know About TRIUMPH-2
New Phase 3 TRIUMPH-2 results put retatrutide back in the spotlight. Here is what the data show, how the triple agonist works, and its regulatory status in Canada.
Retatrutide Phase 3 Results 2026: What Canadians Should Know
New TRIUMPH-2 Phase 3 data show substantial weight loss and A1C reductions with retatrutide. Here is what Canadians should know about the results, current trials, and regulatory status.